{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-5017", "FDA", "Request that the FDA determine whether the Reference Listed Drug (RLD) VELTASSA (PATIROMER SORBITEX CALCIUM) Oral Powder, Eq 25.2 gm Base/Packet; under New Drug Application (NDA) 205739 held by VIFOR PHARMA INC, was voluntarily withdrawn from commercial distribution, or withdrawn from sale for safety or efficacy reasons", "Nonrulemaking", "2026-05-07T19:44:54Z", "0b000064b92c7bf5"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-5017"], "units": {}, "query_ms": 0.6875270046293736, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}